Medical Economics December 11, 2024
Richard Payerchin

Key Takeaways

  • Andrew N. Ferguson’s appointment as FTC chair may alter the agency’s stance on noncompete clauses and PBM regulation.
  • Mark R. Meador, a critic of PBM practices, is nominated as an FTC commissioner, potentially influencing future regulatory actions.
  • Gail Slater will lead the DOJ’s antitrust division, focusing on enforcing competition laws against Big Tech and ensuring fair practices.
  • The FTC’s future direction may involve legislative action on noncompete agreements, as federal regulation lacks precedent.

Ferguson, who opposed ban of noncompetes, named to succeed Chair Khan; new commissioner Meador called for PBM regulations.

Big Tech could be a target but noncompetes are probably a nonstarter when leadership changes and a new commissioner joins the Federal Trade Commission (FTC).

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Provider, Regulations, Technology
Healthcare, medtech industries brace for tariffs
Dr. Mehmet Oz Confirmed as CMS Administrator
Pharma Dodges The Tariff Bullet — But For How Long?
Senate confirms Dr. Oz as CMS administrator: 3 things to know
AI Regulations: House GOP, Democrats Clash on AI Oversight

Share This Article